Get started
Author

Tehreem Fatima

ORCID: 0009-0009-0719-7284
Observed ORCIDs: 0009-0009-0719-7284, 0009-0005-5441-8546
OpenAlex ID: A5114589180
Frexalimab (SAR441344) as a potential multiautoimmune disorder tackling mAB targeting the CD40-CD40L pathway undergoing clinical trials: a review
2024 · Tehreem Fatima, Aeliya Mirza, et al. · Annals of Medicine and Surgery · 12
Efficacy of CRISPR-Cas9 gene editing for targeting KRAS mutations in pancreatic cancer: a systematic review
2025 · Hashim Talib Hashim, Ahmed Qasim Mohammed Alhatemi, et al. · Discover Oncology · 6
PDF
Efficacy and Safety of Olezarsen in Patients With Hypertriglyceridemia: A Meta‐Analysis of Randomized Controlled Trials
2026 · Kainat Feroz, Amna Parvez, et al. · Cardiovascular Therapeutics
Meta‐Analysis to Determine Optimal Timing for Repair of Inguinal Hernia in Pre‐Term Infants
2025 · Tallal Mushtaq Hashmi, Hadiah Ashraf, et al. · World Journal of Surgery
PDF
Clinicopathological features and risk factors of type 1 and type 2 endometrial cancer: A retrospective single-centre analysis.
2025 · Hrithik Dakssesh Putta Nagarajan, Faiza Fatima, et al. · Journal of Clinical Oncology
Palbociclib plus endocrine therapy or GnRH analogs versus capecitabine or placebo for HR+/HER2- metastatic breast cancer: A systematic review and meta-analysis.
2025 · Zaheer Qureshi, Faiza Fatima, et al. · Journal of Clinical Oncology
PDF
Remote Ischemic Preconditioning Promises Cardioprotective and Anti-arrythmic Effects in the Treatment of Atrial Fibrillation: a Systematic Review of Clinical Trials
2025 · Tehreem Fatima, Rukshar Thapa, et al. · Journal of the American College of Cardiology
Cardiovascular Outcomes of Empagliflozin in Patients With and Without Type 2 Diabetes Mellitus; a Meta-analysis of Randomized Controlled Trials
2025 · Tehreem Fatima, Silla Naeem, et al. · Journal of the American College of Cardiology
Works count: 8
Citation count: 18
H-index: 2
I10-index: 1
Year
Topic
Type